← brief for 2026-09-04 · Slowing decline

Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients.

Key takeaways

Researchers looked back at 19,389 adults seen in kidney clinics at one Taiwan medical center between 2013 and 2021. They compared two common drugs that lower uric acid, febuxostat and allopurinol, and asked whether either was linked to becoming frail or getting frailer. Frailty means weakness, slowness, and low energy that make illness and falls more likely. Because the patients chose or were prescribed their own drug, this shows a link only, not proof that one drug causes less frailty than the other.

Who did this work

Lee SY · Wang J · Yoo KD · Chao CT · Chien KL · Hung KY

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 4
https://pubmed.ncbi.nlm.nih.gov/42694867/